JPRN-UMIN000003493招募中2 期
Phase II study of neoadjuvant zoledronic acid therapy for early breast cancer patients - Phase II study of neoadjuvant zoledronic acid therapy
Division of Medical Oncology and Breast Surgery, Cancer Institute Hospital0 个研究点目标入组 30 人开始时间: 2010年4月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) non-invasive or minimally-invasive breast cancer 2) stage IV or inflammatory breast caner 3) male breast cancer 4) Patients who have treated with endocrine therapy, chemotherapy, or radiation therapy 5) Patients with previous or concomitant active malignancy 6) Patients who have serious complication (infection, cardiac disease, lung fibrosis, interstitial pneumonitis, bleeding tendency, etc.) 7) HB hepatitis 8) Patients who have poor-controlled DM 9) Patients who have hypersensitivity to bisphosphonates 10) Patients who needs invasive dental procedures 11) Patients who is pregnant, lactating or willing to be pregnant 12) Other conditions judged as inappropriate for the study by the investigator
研究者
相似试验
已完成
2 期
Phase II study of zoledronic acid concomitant with androgen deprivation therapy for patients with treatment-naive bone-metastatic prostate cancerProstate cancerJPRN-UMIN000007548Kinki University52
已完成
2 期
ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerBreast CancerBreast DiseaseNeoplasmsNeoplasms by SiteNCT01472146Susanne Crocamo58
尚未招募
2 期
Effect of addition of zoledronic acid to chemotherapy in improving the response of tumor before surgery, in women with breast cancer (triple negative subtype)CTRI/2019/09/021060Intramural fund of JIPMER
已完成
不适用
Zoledronic acid injection prevents bone loss in spinal cord injury patientsCTRI/2018/03/012408Dr Satyaranjan Sethi60
招募中
2 期
A phase II clinical trial of zoledronic acid treatment for advanced non-small cell lung cancer with bone metastasis.on-small cell lung cancerJPRN-UMIN000006935Dokkyo Medical University School of Medicine, Department of Pulmonary Medicine and Clinical Immunology40